Skip to content

Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care

Functionality Assessments in Patients (Adults and Children) Following Treatment With Debrase Compared to Standard of Care (SOC) Protocol MW2012-12-12

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01800981
Enrollment
53
Registered
2013-02-28
Start date
2013-03-31
Completion date
Unknown
Last updated
2013-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Lower Extremity, Burns, Upper Extremity

Keywords

Functionality, extremities, ROM, Upper and lower Extremity for burned patients

Brief summary

Once the victim survived the acute phase, the outcome of wound healing, the scarring, became a major medical issue with complications that may lead to cosmetic and functional sequelae. Scar tissue is clinically distinguished from normal skin by an aberrant color, rough surface texture, increased thickness (hypertrophy), contraction, firmness and sometimes, decrease function. Thus, functional and cosmetic outcomes became at least important as wound closure in assessing wound healing products

Detailed description

This is a multi-center, assessor-blinded study aiming to evaluate the long term functionality in adults and children who have participated in study MW2004-11-02 (previous phase 3 study). We had previously shown that by using the MVSS scale which includes objective assessment of the physical characteristics of size, shape, volume, color, texture, and pliability as well as structural, mechanical and physiologic characteristics, lower (favorable) scores in Debrase vs. SOC group were observed in sub-groups of highly functional body parts of the hands and feet. This study will include specific functionality evaluation using the Lower Extremity Functional Scale test for burns in the lower extremities and the QuickDASH outcome measure for burns in the upper extremities as well as range of motion measurements of the joints (knee, ankle, shoulder, elbow and wrist, as relevant).

Interventions

None listed

Sponsors

MediWound Ltd
Lead SponsorINDUSTRY

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to 61 Years
Healthy volunteers
No

Inclusion criteria

* Adults and children who had participated and completed study MW2004-11-02. Patients must be able to sign and dated written informed consent prior to study entry (by Patient or by a guardian, when applicable).

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Functionality evaluation using self reported questionnaires and ROM measurements2-5 years following to acute treatmentFunctionality evaluation of wounds that have been treated by Debrase or SOC during the previous phase 3 study by: 1. Self-report questionnaires designed to measure physical function: the Lower Extremity Functional Scale test for burns in the lower extremities and the QuickDASH outcome measure for burns in the upper extremities. 2. Range of motion measurements of the following injured joints: knee, ankle, shoulder, elbow, wrist palm and fingers, as relevant.

Countries

Slovakia

Contacts

Primary ContactKeren David, MSc
kerend@mediwound.co.il+972-8-9324003
Backup ContactEfrat Hazan, BSc
efrath@mediwound.co.il+972-8-9324051

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026